Antiviral 2,5-disubstituted imidazo[4,5-c]pyridines: From anti-pestivirus to anti-hepatitis C virus activity

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 2, 2007, Pages 390-393

  Puerstinger, Gerhard ^a   Paeshuyse, Jan ^b   De Clercq, Erik ^b   Neyts, Johan ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Antiviral; BVDV inhibitor; HCV inhibitor; Imidazo 4,5 c pyridines

Indexed keywords

5 [(4 BROMOPHENYL)METHYL] 2 PHENYL 5H IMIDAZO[4,5 C]PYRIDINE; ANTIVIRUS AGENT; FLUORINE; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HEPATITIS C VIRUS; NONHUMAN;

ANIMALS; ANTIVIRAL AGENTS; CYTOPATHOGENIC EFFECT, VIRAL; DIARRHEA VIRUSES, BOVINE VIRAL; DRUG DESIGN; DRUG EVALUATION, PRECLINICAL; HEPACIVIRUS; HUMANS; IMIDAZOLES; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; PESTIVIRUS; PYRIDINES; REPLICON; STRUCTURE-ACTIVITY RELATIONSHIP;

BOVINE VIRAL DIARRHEA VIRUS 1; HEPATITIS C VIRUS; PESTIVIRUS;

EID: 33846072581     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.10.039     Document Type: Article

References (13)

1. Bartenschlager R., Frese M., and Pietschmann T. Adv.Virus Res. 63 (2004) 71
2. Pawlotsky J.M. Trends Microbiol. 12 (2004) 96
3. Anonymous. J. Viral Hepat. 6 (1999) 35
4. Craxi A., and Licata A. Semin. Liver Dis. 23 Suppl. 1 (2003) 35
5. Lindberg A.L. Vet. Q. 25 (2003) 1
6. Houe H. Biologicals 31 (2003) 137
7. Puerstinger G., Paeshuyse J., Herdewijn P., Rozenski J., De Clercq E., and Neyts J. Bioorg. Med. Chem. Lett. 16 (2006) 5345
8. Paeshuyse J., Leyssen P., Mabery E., Boddeker N., Vrancken R., Froeyen M., Ansari I.H., Dutartre H., Rozenski J., Gil L.H.V.G., Letellier C., Lanford R., Canard B., Koenen F., Kerkhofs P., Donis R.O., Herdewijn P., Watson J., De Clercq E., Puerstinger G., and Neyts J. J. Virol. 80 (2006) 149
9. + 382.0355; found 382.0358.
10. Robertson D.W., Beedle E.E., Krushinski J.H., Pollock G.D., Wilson H., Wyss V.L., and Hayes J.S. J. Med. Chem. 28 (1985) 717
11. Buckle D.R., Foster K.A., Taylor J.F., Tedder J.M., Thody V.E., Webster R.A.B., Bermudez J., Markwell R.E., and Smith S.A. J. Med. Chem. 30 (1987) 2216
12. 50) was defined as the concentration that inhibited the proliferation of exponentially growing cells by 50% and was calculated using logarithmic interpolation.
13. Choi K.H., Gallei H., Becher P., and Rossmann M.G. Structure 14 (2006) 1107